Calnexin is a novel sero-diagnostic marker for lung cancer

Highlights • Monoclonal antibody for CANX protein was established by the random immunization method. • Serum levels of CANX protein in lung cancer patients were detected by the RPPA method. • CANX protein is a useful early sero-diagnostic marker for lung cancer.

Saved in:

Bibliographic Details
Published in:	Lung cancer (Amsterdam, Netherlands) Vol. 90; no. 2; pp. 342 - 345
Main Authors:	Kobayashi, Makoto, Nagashio, Ryo, Jiang, Shi-Xu, Saito, Keita, Tsuchiya, Benio, Ryuge, Shinichiro, Katono, Ken, Nakashima, Hiroyasu, Fukuda, Eriko, Goshima, Naoki, Satoh, Yukitoshi, Masuda, Noriyuki, Saegusa, Makoto, Sato, Yuichi
Format:	Journal Article
Language:	English
Published:	Ireland Elsevier B.V 01-11-2015
Subjects:	Adenocarcinoma - diagnosis Adenocarcinoma - immunology Adenocarcinoma of Lung Aged Antibodies, Monoclonal - immunology Antibody-based proteomics Antigens, Neoplasm - immunology Biomarkers, Tumor - immunology Calnexin Calnexin - immunology Cell Line, Tumor Female Hematology, Oncology and Palliative Medicine Humans Lung cancer Lung Neoplasms - diagnosis Lung Neoplasms - immunology Male Protein Array Analysis - methods Pulmonary/Respiratory Sero-diagnostic marker Antibody-based proteomics Calnexin Sero-diagnostic marker Lung cancer
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Highlights • Monoclonal antibody for CANX protein was established by the random immunization method. • Serum levels of CANX protein in lung cancer patients were detected by the RPPA method. • CANX protein is a useful early sero-diagnostic marker for lung cancer.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0169-5002 1872-8332
DOI:	10.1016/j.lungcan.2015.08.015